Quick Answer
Sionna Therapeutics, Inc. reported Total Assets of $325.95 million for the year ending 2025.
- Sionna Therapeutics, Inc. showed an increase of +75.5% in Total Assets from 2024 to 2025.
- This data is from Sionna Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $369.67 million | Q2 2025: $352.05 million | Q3 2025: $339.27 million.
- Historical annual values: Fiscal year 2025: $325.95 million | Fiscal year 2024: $185.75 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: